Valuation: Medpace Holdings, Inc.

Market Cap 15.92B 13.92B 12.78B 11.92B 22.59B 1,516B 22.97B 154B 59.62B 744B 59.79B 58.5B 2,562B P/E 2026 *
32.7x
P/E 2027 * 30x
Enterprise Value 14.76B 12.89B 11.84B 11.04B 20.93B 1,405B 21.29B 143B 55.25B 689B 55.41B 54.2B 2,374B EV / Sales 2026 *
5.32x
EV / Sales 2027 * 4.85x
Free-Float
80.38%
Yield 2026 *
-
Yield 2027 * -
1 day+2.58%
1 week+7.24%
Current month+5.29%
1 month+25.14%
3 months+11.89%
6 months-2.35%
Current year-0.72%
1 week 522.94
Extreme 522.945
562.47
1 month 442.95
Extreme 442.95
562.47
Current year 373
Extreme 373
628.92
1 year 306.7
Extreme 306.7035
628.92
3 years 227.21
Extreme 227.21
628.92
5 years 126.94
Extreme 126.945
628.92
10 years 21.76
Extreme 21.76
628.92
Manager TitleAgeSince
Chief Executive Officer 69 1992-06-30
Director of Finance/CFO 51 2021-07-31
Chief Tech/Sci/R&D Officer 65 2017-08-31
Director TitleAgeSince
Chairman 69 1992-06-30
Director/Board Member 55 2016-06-30
Director/Board Member 72 2016-06-30
Date Insider Type Main position Quantity % Market Cap.
05-31Other

Executive/Senior Manager

16,197 0.0567%
05-27Fiscal year

Compliance Officer

49,047 0.1717%
05-14Other

Director

1,110 0.0039%
Change 5-day change 1-year change 3-year change Capi.($)
+2.58%+7.24%+71.03%+132.17% 15.92B
+0.53%+5.95%+1.72%+6.99% 49.15B
+0.92%+6.21%+408.85%+607.44% 40.23B
+1.89%+11.06%+25.75%-7.89% 34.55B
+2.38%+8.10%+21.83%+66.94% 33.09B
+1.20%+2.02%+9.79%+32.43% 25.19B
+2.51%+4.94% - - 17.05B
+0.17%+0.44%+13.50%+18.92% 13.83B
-1.14%+7.52%+14.75%-30.83% 13.26B
+3.30%+4.42%+87.66%+99.37% 13.52B
Average +1.43%+6.23%+72.76%+102.84% 25.58B
Weighted average by Cap. +1.38%+6.61%+88.34%+129.19%

Financials

2026 *2027 *
Net sales 2.77B 2.42B 2.23B 2.08B 3.94B 264B 4B 26.8B 10.39B 130B 10.42B 10.19B 446B 2.95B 2.58B 2.36B 2.21B 4.18B 281B 4.25B 28.47B 11.03B 138B 11.07B 10.83B 474B
Net income 492M 430M 395M 368M 698M 46.87B 710M 4.76B 1.84B 22.99B 1.85B 1.81B 79.21B 539M 471M 433M 403M 765M 51.33B 778M 5.21B 2.02B 25.18B 2.02B 1.98B 86.76B
Net Debt -1.17B -1.02B -938M -875M -1.66B -111B -1.69B -11.29B -4.38B -54.59B -4.39B -4.29B -188B -1.62B -1.41B -1.3B -1.21B -2.3B -154B -2.33B -15.63B -6.06B -75.55B -6.07B -5.94B -260B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,300
Date Price Change Volume
26-07-02 US$557.60 +2.58% 356,575
26-07-01 US$543.57 +2.64% 312,635
26-06-30 US$529.59 -0.96% 335,554
26-06-29 US$534.72 +1.45% 390,789
26-06-26 US$527.07 +1.37% 399,920
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
557.60USD
Average target price
443.50USD
Spread / Average Target
-20.46%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock